NCT01085708

A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: Eisai Co., Ltd. · Industry
• Sex: Male
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess pharmacokinetics of rabeprazole under postprandial condition.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	rabeprazole	10 mg normal tablet
DRUG	rabeprazole	Type 1 granule containing rabeprazole 10 mg
DRUG	rabeprazole	Type 2 granules containing rabeprazole 10 mg
DRUG	rabeprazole	Type 3 granules containing rabeprazole 10 mg

Timeline

• Start date: 2010-04-01
• Primary completion: 2010-05-01
• Completion: 2010-05-01
• First posted: 2010-03-12
• Last updated: 2013-05-13